These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Long noncoding RNA MEG3 decreases the growth of head and neck squamous cell carcinoma by regulating the expression of miR-421 and E-cadherin. Ji Y; Feng G; Hou Y; Yu Y; Wang R; Yuan H Cancer Med; 2020 Jun; 9(11):3954-3963. PubMed ID: 32277605 [TBL] [Abstract][Full Text] [Related]
43. High expression of ACTL8 is poor prognosis and accelerates cell progression in head and neck squamous cell carcinoma. Li B; Zhu J; Meng L Mol Med Rep; 2019 Feb; 19(2):877-884. PubMed ID: 30535476 [TBL] [Abstract][Full Text] [Related]
44. UBE2C promotes the progression of head and neck squamous cell carcinoma. Jin Z; Zhao X; Cui L; Xu X; Zhao Y; Younai F; Messadi D; Hu S Biochem Biophys Res Commun; 2020 Mar; 523(2):389-397. PubMed ID: 31870550 [TBL] [Abstract][Full Text] [Related]
45. Comprehensive analysis of the expression and prognosis for CDCAs in head and neck squamous cell carcinoma. Wu ZH; Fang M; Zhou Y PLoS One; 2020; 15(7):e0236678. PubMed ID: 32716971 [TBL] [Abstract][Full Text] [Related]
46. Use of Diffusion-Weighted Imaging and Noij DP; Martens RM; Koopman T; Hoekstra OS; Comans EFI; Zwezerijnen B; de Bree R; de Graaf P; Castelijns JA Clin Oncol (R Coll Radiol); 2018 Dec; 30(12):780-792. PubMed ID: 30318343 [TBL] [Abstract][Full Text] [Related]
47. Overexpression of ZEB2-AS1 promotes epithelial-to-mesenchymal transition and metastasis by stabilizing ZEB2 mRNA in head neck squamous cell carcinoma. Diao P; Ge H; Song Y; Wu Y; Li J; Li Z; Yang J; Wang Y; Cheng J J Cell Mol Med; 2019 Jun; 23(6):4269-4280. PubMed ID: 30950191 [TBL] [Abstract][Full Text] [Related]
48. BP180 Is a Prognostic Factor in Head and Neck Squamous Cell Carcinoma. Meng X; Matsumoto F; Mori T; Miura N; Ino Y; Onidani K; Kobayashi K; Matsuzaki Y; Yoshimoto S; Ikeda K; Honda K Anticancer Res; 2021 Feb; 41(2):1089-1099. PubMed ID: 33517320 [TBL] [Abstract][Full Text] [Related]
49. Analysis of methylation-driven genes for predicting the prognosis of patients with head and neck squamous cell carcinoma. Pan Y; Song Y; Cheng L; Xu H; Liu J J Cell Biochem; 2019 Dec; 120(12):19482-19495. PubMed ID: 31264288 [TBL] [Abstract][Full Text] [Related]
50. An Integrated Approach Identifies Mediators of Local Recurrence in Head and Neck Squamous Carcinoma. Citron F; Armenia J; Franchin G; Polesel J; Talamini R; D'Andrea S; Sulfaro S; Croce CM; Klement W; Otasek D; Pastrello C; Tokar T; Jurisica I; French D; Bomben R; Vaccher E; Serraino D; Belletti B; Vecchione A; Barzan L; Baldassarre G Clin Cancer Res; 2017 Jul; 23(14):3769-3780. PubMed ID: 28174235 [No Abstract] [Full Text] [Related]
51. Potentially novel candidate biomarkers for head and neck squamous cell carcinoma identified using an integrated cell line-based discovery strategy. Sepiashvili L; Hui A; Ignatchenko V; Shi W; Su S; Xu W; Huang SH; O'Sullivan B; Waldron J; Irish JC; Perez-Ordonez B; Liu FF; Kislinger T Mol Cell Proteomics; 2012 Nov; 11(11):1404-15. PubMed ID: 22918226 [TBL] [Abstract][Full Text] [Related]
52. Identification and analysis of genes associated with head and neck squamous cell carcinoma by integrated bioinformatics methods. Jin Y; Yang Y Mol Genet Genomic Med; 2019 Aug; 7(8):e857. PubMed ID: 31304688 [TBL] [Abstract][Full Text] [Related]
53. Prognostic capacity of the transcriptional expression of lactate dehydrogenase A in patients with head and neck squamous cell carcinoma. Bagué S; León X; Terra X; Lejeune M; Camacho M; Avilés-Jurado FX Head Neck; 2022 Nov; 44(11):2505-2512. PubMed ID: 36207788 [TBL] [Abstract][Full Text] [Related]
54. Immuno-radiotherapy with cetuximab and avelumab for advanced stage head and neck squamous cell carcinoma: Results from a phase-I trial. Elbers JBW; Al-Mamgani A; Tesseslaar MET; van den Brekel MWM; Lange CAH; van der Wal JE; Verheij M; Zuur CL; de Boer JP Radiother Oncol; 2020 Jan; 142():79-84. PubMed ID: 31563412 [TBL] [Abstract][Full Text] [Related]
55. Development and validation of a RNA binding protein-associated prognostic model for head and neck squamous cell carcinoma. Yang X; Han B; Zhang R; Su Y; Hosseini DK; Wu H; Yang M; Sun H Aging (Albany NY); 2021 Mar; 13(6):7975-7997. PubMed ID: 33758106 [TBL] [Abstract][Full Text] [Related]
56. Integrin alpha 6 as a stemness driver is a novel promising target for HPV (+) head and neck squamous cell carcinoma. An JS; Moon JH; Kim C; No JK; Eun YG; Chang Lim Y Exp Cell Res; 2021 Oct; 407(2):112815. PubMed ID: 34496296 [TBL] [Abstract][Full Text] [Related]
57. The Krüppel-like factor 6 represses proliferation and invasion of cutaneous malignant melanoma. Li YY; Zheng QM; Zhang N; Zhang M Pol J Pathol; 2023; 74(3):194-202. PubMed ID: 37955538 [TBL] [Abstract][Full Text] [Related]
58. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma. Zhang F; Liu Y; Yang Y; Yang K BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731 [TBL] [Abstract][Full Text] [Related]
59. Development and validation of a novel ferroptosis-related gene signature for predicting prognosis and immune microenvironment in head and neck squamous cell carcinoma. He F; Chen Z; Deng W; Zhan T; Huang X; Zheng Y; Yang H Int Immunopharmacol; 2021 Sep; 98():107789. PubMed ID: 34130150 [TBL] [Abstract][Full Text] [Related]
60. Predictive capacity of IL-8 expression in head and neck squamous carcinoma patients treated with radiotherapy or chemoradiotherapy. León X; García J; Farré N; Majercakova K; Avilés-Jurado FX; Quer M; Camacho M Acta Otorrinolaringol Esp (Engl Ed); 2020 Sep; ():. PubMed ID: 32972719 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]